47366 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 27
09:45 UTC
|
MAC
Macerich
|
↑ Upgrade | Alexander Goldfarb ★★★☆☆ #1274 | Neutral→ Overweight | |
|
Aug 27
00:44 UTC
|
ZYME
Zymeworks
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2797 | Buy | $37.00→ $38.00+2.7% |
|
Aug 27
00:44 UTC
|
ZYME
Zymeworks
|
◎ Target | Robert Burns ★☆☆☆☆ #2973 | Buy | $51.00→ $55.00+7.8% |
|
Aug 27
00:44 UTC
|
ZS
Zscaler
|
◎ Target | Brian Essex ★★★★☆ #678 | Overweight | $205.00→ $215.00+4.9% |
|
Aug 27
00:44 UTC
|
ZM
Zoom Communications
|
◎ Target | Meta Marshall ★★★★☆ #464 | Equal Weight | $105.00→ $107.00+1.9% |
|
Aug 27
00:44 UTC
|
ZM
Zoom Communications
|
◎ Target | Samad Samana ★★★★★ #102 | Buy | $118.00→ $116.00-1.7% |
|
Aug 27
00:44 UTC
|
WTB
Whitbread
|
◎ Target | firm only | Hold | GBX 2,050→ GBX 2,250+9.8% |
|
Aug 27
00:44 UTC
|
WT
WisdomTree
|
◎ Target | Chris Kotowski ★★★★☆ #744 | Outperform | $22.00→ $27.00+22.7% |
|
Aug 27
00:44 UTC
|
VMRK
Vivmark Residential Common Shares of Beneficial Interest
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1274 | Neutral | $75.00→ $76.00+1.3% |
|
Aug 27
00:44 UTC
|
UGP
Ultrapar Participacoes
|
◎ Target | Bruno Amorim ★★★☆☆ #1167 | Neutral | $6.50→ $5.80-10.8% |
|
Aug 27
00:44 UTC
|
TECK.B
Teck Resources
|
◎ Target | firm only | Outperform | C$93.00→ C$105.00+12.9% |
|
Aug 27
00:44 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | David Hoang ★★☆☆☆ #2418 | Buy | $135.00→ $127.00-5.9% |
|
Aug 27
00:44 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | Julian Harrison ★★☆☆☆ #2886 | Buy | $132.00→ $121.00-8.3% |
|
Aug 27
00:44 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | David Nierengarten ★★☆☆☆ #2451 | Outperform | $130.00→ $123.00-5.4% |
|
Aug 27
00:44 UTC
|
SNOW
Snowflake
|
◎ Target | Tyler Radke ★★★★★ #109 | Buy | $320.00→ $395.00+23.4% |
|
Aug 27
00:44 UTC
|
SMTC
Semtech
|
◎ Target | Timothy Arcuri ★★★☆☆ #1937 | Buy | $225.00→ $230.00+2.2% |
|
Aug 27
00:44 UTC
|
SMTC
Semtech
|
◎ Target | Joseph Moore ★★★☆☆ #1676 | Equal Weight | $175.00→ $195.00+11.4% |
|
Aug 27
00:44 UTC
|
SMPL
Simply Good Foods
|
◎ Target | Robert Moskow ★★★★☆ #785 | Hold | $13.00→ $11.00-15.4% |
|
Aug 27
00:44 UTC
|
REPL
Replimune Group
|
◎ Target | Anupam Rama ★★☆☆☆ #2855 | Overweight | $20.00→ $21.00+5.0% |
|
Aug 27
00:44 UTC
|
RBRK
Rubrik
|
◎ Target | Blair Abernethy ★★★★★ #246 | Buy | $95.00→ $105.00+10.5% |
|
Aug 27
00:44 UTC
|
QUBT
Quantum Computing
|
◎ Target | Edward Woo ★☆☆☆☆ #3202 | Buy | $30.00→ $32.00+6.7% |
|
Aug 27
00:44 UTC
|
PSTL
Postal Realty Trust
|
◎ Target | Anthony Paolone ★★★☆☆ #1285 | Neutral | $23.00→ $25.00+8.7% |
|
Aug 27
00:44 UTC
|
OLLI
Ollie's Bargain Outlet
|
◎ Target | Steven Zaccone ★★★★☆ #775 | Buy | $111.00→ $100.00-9.9% |
|
Aug 27
00:44 UTC
|
NTSK
Netskope
|
◎ Target | Brian Essex ★★★★☆ #678 | Overweight | $14.00→ $16.00+14.3% |
|
Aug 27
00:44 UTC
|
NI
NiSource
|
◎ Target | Gabriel Moreen not yet tracked | Outperform | $50.00→ $48.00-4.0% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Ryan Tomasello ★★★★☆ #657 | Outperform | $24.00→ $25.00+4.2% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | James Faucette ★★★☆☆ #1237 | Overweight | $23.00→ $25.00+8.7% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Saket Kalia ★★★★★ #110 | Overweight | $22.00→ $23.00+4.5% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Aaron Kimson ★★★★☆ #918 | Market Outperform | $23.00→ $25.00+8.7% |
|
Aug 27
00:44 UTC
|
NCNO
nCino
|
◎ Target | Terry Tillman ★★★★★ #221 | Hold | $19.00→ $20.00+5.3% |
|
Aug 27
00:44 UTC
|
MZTI
Marzetti
|
◎ Target | Brian Holland ★★☆☆☆ #2885 | Neutral | $168.00→ $130.00-22.6% |
|
Aug 27
00:44 UTC
|
MDB
MongoDB
|
◎ Target | Rudy Kessinger ★★★★★ #60 | Buy | $375.00→ $465.00+24.0% |
|
Aug 27
00:44 UTC
|
MDB
MongoDB
|
◎ Target | Raimo Lenschow ★★★★★ #273 | Overweight | $387.00→ $460.00+18.9% |
|
Aug 27
00:44 UTC
|
MCD
McDonald's
|
◎ Target | John Staszak ★★☆☆☆ #2655 | Buy | $320.00→ $310.00-3.1% |
|
Aug 27
00:44 UTC
|
MANH
Manhattan Associates
|
◎ Target | Joe Vruwink not yet tracked | Outperform | $218.00→ $260.00+19.3% |
|
Aug 27
00:44 UTC
|
M
Macy's
|
◎ Target | Jay Sole ★★★☆☆ #2172 | Sell | $9.00→ $10.00+11.1% |
|
Aug 27
00:44 UTC
|
LB
LandBridge
|
◎ Target | Spiro Dounis not yet tracked | Neutral | $66.00→ $86.00+30.3% |
|
Aug 27
00:44 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Jeffrey Hung not yet tracked | Overweight | $283.00→ $322.00+13.8% |
|
Aug 27
00:44 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Gregory Renza ★★★☆☆ #1438 | Buy | $264.00→ $281.00+6.4% |
|
Aug 27
00:44 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Ami Fadia ★★☆☆☆ #2384 | Buy | $292.00→ $310.00+6.2% |
|
Aug 27
00:44 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Gregg Gilbert not yet tracked | Buy | $287.00→ $300.00+4.5% |
|
Aug 27
00:44 UTC
|
INVX
Innovex International
|
◎ Target | Scott Gruber ★★★☆☆ #1202 | Buy | $35.00→ $36.00+2.9% |
|
Aug 27
00:44 UTC
|
INTU
Intuit
|
◎ Target | Adam Wood ★★★★☆ #821 | Equal Weight | $335.00→ $315.00-6.0% |
|
Aug 27
00:44 UTC
|
INTU
Intuit
|
◎ Target | James Friedman ★★★☆☆ #1401 | Positive | $427.00→ $415.00-2.8% |
|
Aug 27
00:44 UTC
|
INTU
Intuit
|
◎ Target | Raimo Lenschow ★★★★★ #273 | Overweight | $443.00→ $408.00-7.9% |
|
Aug 27
00:44 UTC
|
INTU
Intuit
|
◎ Target | Michael Turrin ★★★★☆ #709 | Equal Weight | $360.00→ $300.00-16.7% |
|
Aug 27
00:44 UTC
|
INTU
Intuit
|
◎ Target | Scott Schneeberger ★★★☆☆ #2047 | Outperform | $406.00→ $380.00-6.4% |
|
Aug 27
00:44 UTC
|
INTU
Intuit
|
◎ Target | Billy Fitzsimmons ★★★★★ #86 | Underweight | $250.00→ $290.00+16.0% |
|
Aug 27
00:44 UTC
|
INTU
Intuit
|
◎ Target | Arvind Ramnani ★★★☆☆ #2098 | Hold | $350.00→ $300.00-14.3% |
|
Aug 27
00:44 UTC
|
GTLB
GitLab
|
◎ Target | Brian Essex ★★★★☆ #678 | Neutral | $32.00→ $44.00+37.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.